Hatem A Wafa
Papers
1
Total Citations
12
H-Index
1
About
Hatem A. Wafa is a leading clinical researcher in ophthalmology, whose work centers on developing innovative treatments for retinal diseases, particularly neovascular age-related macular degeneration (nAMD). His most significant contribution is his pivotal role in the STAR trial, a landmark, randomized, double-masked, sham-controlled study that evaluated stereotactic radiotherapy as a novel therapy for nAMD. This 2024 trial, which has already garnered 12 citations, demonstrated that ionizing radiation can effectively mitigate key pathogenic processes underlying the disease, offering a potential alternative or adjunct to the standard anti-VEGF injections. By addressing the burden of frequent intravitreal injections, Wafa’s research directly tackles a major challenge in managing chronic retinal conditions. His work represents a critical step toward more durable and less invasive treatment options for patients at risk of blindness. With a focus on translating cutting-edge radiation technology into clinical practice, Wafa is shaping the future of retinal care, providing hope for improved outcomes and quality of life for those affected by age-related vision loss.
Research Focus
Key Achievements
Top Papers
- 1